Cytodyn Inc (CYDY)

[B52T38]

Howard, Just read a little on Novavax and their vaccine.

Based on what I read, I wouldn't invest too much into a company that's still months away with Phase 3 results, especially considering the US govt bought enough existing Pfizer and Moderna vaccine for pretty much all the USA. There's still the rest of Earth, but the vaccine field seems crowded.

So given the nearly $300 SP of Novavax - if our severe/critical results show statistical sig - what's your estimate of where CYDY will (or could) be by 1 June 2020? I know you mention market cap as something that precludes an apples-apples comparison with CYDY, but honestly, I don't think too many retail investors consider a company's market cap before they hit "Buy."

Thanks!